Inter-day Reliability of the Oral Glucose Tolerance Test Using Indirect Calorimetry

Overview

The main aim of this study is to determine the inter-day reliability, by using indirect calorimetry, of the post-prandial macronutrient oxidation and energy expenditure after consuming oral glucose load solution.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 2020

Detailed Description

The maintenance of blood glucose concentrations and the oxidation of carbohydrate after consuming carbohydrate is related with a low risk of mortality and morbidity from cardiometabolic diseases. The oral glucose tolerance test is a diagnostic test widely used in the clinical field. However, its inter-day reliability has not been deeply studied. Therefore, it is of clinical interest to study the inter-day reliability of the diagnostic test oral glucose tolerance test using indirect calorimetry and monitoring the response of the glucose levels. 20 young adults will undergo two trials visit with 7 days of separation between conditions. Each evaluation day will conform to the following tests: 1. Basal metabolic rate assessment through indirect calorimetry. 2. Basal heart rate variability through heart rate monitor. 3. Intake of the corresponding glucose load solution. 4. Postprandial nutrient oxidation and energy expenditure assessment through indirect calorimetry 5. Glucose monitoring through Glucose meter.

Interventions

  • Diagnostic Test: Oral glucose tolerance test
    • Participants will ingest 75g anhydrous glucose dissolved in a volume of 200mL of water (NUTER.TEC GLUCOS, Subra, Toulouse, France).

Arms, Groups and Cohorts

  • Experimental: Experimental
    • Participants will undergo two trials visit (with a week of separation). During the visits they will ingest an oral glucose load solution (oral glucose tolerance test) and gas exchange will be measured over the following 3-hours. The glucose levels will be monitored through a Glucose meter in different time frames.

Clinical Trial Outcome Measures

Primary Measures

  • Inter-day reliability, 7 days apart, in post-prandial nutrient oxidation
    • Time Frame: 7 days
    • Reliability

Secondary Measures

  • Inter-day reliability, 7 days apart, in post-prandial energy expenditure
    • Time Frame: 7 days
    • Reliability
  • Inter-day reliability, 7 days apart, in glucose levels
    • Time Frame: 7 days
    • Reliability

Participating in This Clinical Trial

Inclusion Criteria

  • Healthy male or female – Ages 18-30 years – BMI: 18-27.5 kg/m2 – Stable weight over the last 3 months (body weight changes<35kg) – Participant must be capable and willing to provide consent, understand exclusion criteria, instructions and protocols. Exclusion Criteria:

  • History of cardiovascular disease – Diabetes or hypertension – Pregnant, planning to become pregnant, or breastfeeding – Have been treated previously or during the study period with prescription drugs: antihypertensive, lipid lowering, acid uric lowering, glucose lowering, beta blockers or any drug that under the investigator's judged could influence the results. – Any non-controlled medical condition which could influence results or could be worsened by the participation in the study. – Claustrophobia – Needle phobia – Are deemed unsuitable by the investigator for any other reason, that prevent data collection.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 30 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Universidad de Granada
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jonatan Ruiz Ruiz, Associate professor – Universidad de Granada
  • Overall Official(s)
    • juanma.alcantara@hotmail.com Ruiz Ruiz, Dr., Principal Investigator, Universidad de Granada
  • Overall Contact(s)
    • Jonatan Ruiz Ruiz, Dr., 958242754, ruizj@ugr.es

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.